Evidence map›Paper›PMID 26203192›Full record

ArticleThe Journal of biological chemistry2015

Hepatitis C Virus Particle Assembly Involves Phosphorylation of NS5A by the c-Abl Tyrosine Kinase.

Shota Yamauchi, Kenji Takeuchi, Kazuyasu Chihara, Xuedong Sun, Chisato Honjoh, Hatsumi Yoshiki, Hak Hotta, Kiyonao Sada

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Role of c-ABL in DENV-2 Infection and Actin Remodeling in Vero Cells.International journal of molecular sciences · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Shota YamauchiFrom the Division of Genome Science and Microbiology, Department of Pathological Sciences, Faculty of Medical Sciences, the Organization for Life Science Advancement Programs, University of Fukui, Fukui 910-1193, Japan and.
Kenji TakeuchiFrom the Division of Genome Science and Microbiology, Department of Pathological Sciences, Faculty of Medical Sciences, the Organization for Life Science Advancement Programs, University of Fukui, Fukui 910-1193, Japan and.
Kazuyasu ChiharaFrom the Division of Genome Science and Microbiology, Department of Pathological Sciences, Faculty of Medical Sciences, the Organization for Life Science Advancement Programs, University of Fukui, Fukui 910-1193, Japan and.
Xuedong SunFrom the Division of Genome Science and Microbiology, Department of Pathological Sciences, Faculty of Medical Sciences.
Chisato HonjohFrom the Division of Genome Science and Microbiology, Department of Pathological Sciences, Faculty of Medical Sciences, the Third Department of Internal Medicine, Faculty of Medical Sciences, and.
Hatsumi YoshikiFrom the Division of Genome Science and Microbiology, Department of Pathological Sciences, Faculty of Medical Sciences.
Hak Hottathe Division of Microbiology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Kiyonao SadaFrom the Division of Genome Science and Microbiology, Department of Pathological Sciences, Faculty of Medical Sciences, the Organization for Life Science Advancement Programs, University of Fukui, Fukui 910-1193, Japan and ksada@u-fukui.ac.jp.
University of Fukui · JPKobe University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatitis C virus (HCV) nonstructural protein 5A (NS5A) is thought to regulate the replication of viral RNA and the assembly of virus particles in a serine/threonine phosphorylation-dependent manner. However, the host kinases that phosphorylate NS5A have not been fully identified. Here, we show that HCV particle assembly involves the phosphorylation of NS5A by the c-Abl tyrosine kinase. Pharmacological inhibition or knockdown of c-Abl reduces the production of infectious HCV (J6/JFH1) particles in Huh-7.5 cells without markedly affecting viral RNA translation and replication. NS5A is tyrosine-phosphorylated in HCV-infected cells, and this phosphorylation is also reduced by the knockdown of c-Abl. Mutational analysis reveals that NS5A tyrosine phosphorylation is dependent, at least in part, on Tyr(330) (Tyr(2306) in polyprotein numbering). Mutation of this residue to phenylalanine reduces the production of infectious HCV particles but does not affect the replication of the JFH1 subgenomic replicon. These findings suggest that c-Abl promotes HCV particle assembly by phosphorylating NS5A at Tyr(330).

Indexed as

Virus AssemblyAnimalsCell Line, TumorChlorocebus aethiopsCOS CellsHEK293 CellsHepacivirusHost-Pathogen InteractionsHumansImmunoblottingMicroscopy, ConfocalPhosphorylationProto-Oncogene Proteins c-ablReverse Transcriptase Polymerase Chain ReactionRNA-Dependent RNA PolymeraseRNA InterferenceNS-5 protein, hepatitis C virusProto-Oncogene Proteins c-ablRNA-Dependent RNA PolymeraseRNA, ViralTyrosineViral Nonstructural ProteinsABL tyrosine kinasehepatitis C virus (HCV)host-pathogen interactionvirologyvirus assembly

Identifiers

PMID26203192
PMCPMC4571941
OpenAlexW2141356256

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.